ProShare Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $17.6K | Sell |
|
|||||
|
2024
Q4 | $20.9K | Buy |
|
|||||
|
2024
Q3 | $25.3K | Buy |
|
|||||
|
2024
Q2 | $17.7K | Sell |
|
|||||
|
2024
Q1 | $35.3K | Buy |
|
|||||
|
2023
Q4 | $23.9K | Buy |
|
|||||
|
2023
Q3 | $19.8K | Sell |
|
|||||
|
2023
Q2 | $23.7K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $36K | Sell |
|
|||||
|
2021
Q4 | $67K | Buy |
|
|||||
|
2021
Q3 | $40K | Sell |
|
|||||
|
2021
Q2 | $90K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $13K | Buy |
|
|||||
|
2019
Q3 | $12K | Buy |
|
|||||
|
2019
Q2 | $13K | Sell |
|
|||||
|
2019
Q1 | $16K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $26K | Sell |
|
|||||
|
2018
Q2 | $24K | Buy |
|
|||||
|
2018
Q1 | $30K | Sell |
|
|||||
|
2017
Q4 | $28K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $40K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $50K | Sell |
|
|||||
|
2014
Q4 | $42K | Sell |
|
|||||
|
2014
Q3 | $65K | Sell |
|
|||||
|
2014
Q2 | $77K | Sell |
|
|||||
|
2014
Q1 | $123K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $89K | Buy |
|
|||||
|
2013
Q2 | $87K | Buy |
|